According to vTv Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.24. In 2022 the company made an earnings per share (EPS) of -$0.25 a decrease over its 2021 EPS that were of -$0.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.24 | -4% |
2022 | -$0.25 | 13.64% |
2021 | -$0.22 | 15.79% |
2020 | -$0.19 | -69.35% |
2019 | -$0.62 | -19.48% |
2018 | -$0.77 | -53.89% |
2017 | -$1.67 | -2.91% |
2016 | -$1.72 | -30.42% |
2015 | -$2.47 | 124.66% |
2014 | -$1.10 |